Details for New Drug Application (NDA): 019183
✉ Email this page to a colleague
NDA 019183 describes CARAFATE, which is a drug marketed by Abbvie and is included in two NDAs. It is available from thirteen suppliers. Additional details are available on the CARAFATE profile page.
The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 019183
| Tradename: | CARAFATE |
| Applicant: | Abbvie |
| Ingredient: | sucralfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 019183
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CARAFATE | sucralfate | SUSPENSION;ORAL | 019183 | NDA AUTHORIZED GENERIC | Par Pharmaceutical Inc. | 0254-1011 | 0254-1011-96 | 420 mL in 1 BOTTLE (0254-1011-96) |
| CARAFATE | sucralfate | SUSPENSION;ORAL | 019183 | NDA AUTHORIZED GENERIC | ATLANTIC BIOLOGICALS CORP. | 17856-1011 | 17856-1011-1 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1011-1) / 10 mL in 1 CUP, UNIT-DOSE (17856-1011-2) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 1GM/10ML | ||||
| Approval Date: | Dec 16, 1993 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
